Boston Financial Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,721
| Closed | -$212K | – | 337 |
|
|
2024
Q3 | $212K | Hold |
2,721
| – | – | 0.01% | 317 |
|
|
2024
Q2 | $212K | Buy |
+2,721
| New | +$212K | 0.01% | 316 |
|
|
2022
Q3 | – | Sell |
-3,125
| Closed | -$206K | – | 304 |
|
|
2022
Q2 | $206K | Buy |
+3,125
| New | +$206K | 0.01% | 280 |
|
|
2020
Q3 | – | Sell |
-3,248
| Closed | -$172K | – | 237 |
|
|
2020
Q2 | $172K | Hold |
3,248
| – | – | 0.01% | 242 |
|
|
2020
Q1 | $145K | Sell |
3,248
-1,700
| -34% | -$75.9K | 0.01% | 251 |
|
|
2019
Q4 | $247K | Hold |
4,948
| – | – | 0.01% | 220 |
|
|
2019
Q3 | $221K | Buy |
+4,948
| New | +$221K | 0.01% | 242 |
|
|
2019
Q2 | – | Sell |
-82,428
| Closed | -$3.33M | – | 258 |
|
|
2019
Q1 | $3.33M | Sell |
82,428
-3,132
| -4% | -$127K | 0.2% | 100 |
|
|
2018
Q4 | $3.25M | Sell |
85,560
-990
| -1% | -$37.6K | 0.23% | 97 |
|
|
2018
Q3 | $3.43M | Sell |
86,550
-2,480
| -3% | -$98.1K | 0.2% | 104 |
|
|
2018
Q2 | $3.13M | Sell |
89,030
-14,002
| -14% | -$492K | 0.21% | 109 |
|
|
2018
Q1 | $3.6M | Sell |
103,032
-11,770
| -10% | -$412K | 0.25% | 105 |
|
|
2017
Q4 | $3.98M | Sell |
114,802
-7,665
| -6% | -$266K | 0.27% | 105 |
|
|
2017
Q3 | $4.15M | Sell |
122,467
-3,980
| -3% | -$135K | 0.3% | 108 |
|
|
2017
Q2 | $4.31M | Buy |
126,447
+7,642
| +6% | +$261K | 0.31% | 107 |
|
|
2017
Q1 | $3.7M | Buy |
118,805
+3,950
| +3% | +$123K | 0.28% | 116 |
|
|
2016
Q4 | $3.14M | Buy |
114,855
+18,910
| +20% | +$517K | 0.25% | 125 |
|
|
2016
Q3 | $3.15M | Sell |
95,945
-1,200
| -1% | -$39.4K | 0.26% | 127 |
|
|
2016
Q2 | $2.93M | Buy |
+97,145
| New | +$2.93M | 0.24% | 133 |
|